<?xml version="1.0" encoding="UTF-8"?>
<ref id="B78-ijms-22-00634">
 <label>78.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Okuno</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Aoyama</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Oba</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yokoyama</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Matsuhashi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kunieda</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Nishimura</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Akamatsu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kobatake</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Morita</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Randomized phase III trial comparing surgery alone to UFT+PSK for stage II rectal cancer (JFMC38 trial)</article-title>
  <source>Cancer Chemother. Pharmacol.</source>
  <year>2018</year>
  <volume>81</volume>
  <fpage>65</fpage>
  <lpage>71</lpage>
  <pub-id pub-id-type="doi">10.1007/s00280-017-3466-7</pub-id>
  <pub-id pub-id-type="pmid">29094178</pub-id>
 </element-citation>
</ref>
